<DOC>
	<DOCNO>NCT02522130</DOCNO>
	<brief_summary>Different way reduce pain IUD insertion explore . So randomized study conduct test role</brief_summary>
	<brief_title>Different Analgesics Prior Intrauterine Device ( IUD ) Insertion : Is There Any Evidence ?</brief_title>
	<detailed_description>A randomized clinical control trial woman undergo IUD insertion . Participants study group randomly assign label opaque envelope either1 % lidocaine ( Xylocaine 1 % , Astra Zeneca , Egypt ) , misoprostol ( Sigma , Egypt ) , naproxen ( Naprosyn , Syntax , Egypt ) placebo tablet .</detailed_description>
	<mesh_term>Lidocaine</mesh_term>
	<mesh_term>Naproxen</mesh_term>
	<mesh_term>Analgesics</mesh_term>
	<mesh_term>Misoprostol</mesh_term>
	<criteria>Patients consider eligible : 1. alert orient cooperative response visual analogue scale ( VAS ) . 2 . They sign inform consent participate clinical trial enter study . 3 . Willingness randomize complete study questionnaire . Participants exclude participation ineligible IUD accept criterion institution : 1 . A lidocaine allergy 2 . Copper allergy 3 . Current cervicitis 4 . Pelvic inflammatory disease ( PID ) within 3 month 5 . Uterine anomaly 6 . Pain medication within 6 hour insertion 7 . Misoprostol administration within 24 hour insertion 8 . History cervical surgery contraindication study medication .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>